Pfizer Independent Medical Education Grant Request for Proposals: Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia Areata
Funds educational programs to advance healthcare professionals’ understanding of JAK3 and TEC kinase science and dual inhibition therapies in alopecia areata.
Funder: Pfizer Inc.
Due Dates: May 25, 2026 (Submission deadline, full application)
Funding Amounts: Up to $100,000 per project; total available budget $200,000; project duration up to 1 year
Summary: Supports educational programs for healthcare professionals to enhance understanding of JAK3 and TEC kinase mechanisms in alopecia areata.
Key Information: Only organizations (not individuals or medical practice groups) based in the US are eligible.
Description
This grant opportunity invites qualified educational providers to develop and deliver a comprehensive educational program for dermatologists and healthcare professionals, focusing on the mechanism of action of JAK3 and TEC family kinases in alopecia areata. The goal is to address knowledge gaps regarding dual inhibition therapies and the therapeutic benefits of targeting these pathways in alopecia areata treatment. Programs must be scientifically rigorous, aligned with current research, and include evaluation metrics for educational effectiveness and participant learning outcomes.
